Johns Hopkins ABX Guide
Aztreonam
INDICATIONS
FDA
FDA
- Gram-negative bacterial pneumonia
- Skin and soft tissue infections (caused by Gram-negative bacilli)
- Complicated and uncomplicated urinary tract infections
- Intra-abdominal infections (in combination with metronidazole)
- Septicemia (cause by Gram-negative bacilli)
- Gynecologic infections (in combination with anaerobic coverage)
- Nebulized aztreonam is indicated for treatment of respiratory symptoms in cystic fibrosis (CF patients with FEV1 of 25-75% of predicted) with P. aeruginosa
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Alternative therapy for treatment of Gram-negative infections in patients with severe allergies
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: June 3, 2017
Citation
Avdic, Edina, and Paul A Pham. "Aztreonam." Johns Hopkins ABX Guide, The Johns Hopkins University, 2017. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540041/all/Aztreonam.
Avdic E, Pham PA. Aztreonam. Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540041/all/Aztreonam. Accessed June 10, 2023.
Avdic, E., & Pham, P. A. (2017). Aztreonam. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540041/all/Aztreonam
Avdic E, Pham PA. Aztreonam [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. [cited 2023 June 10]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540041/all/Aztreonam.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aztreonam
ID - 540041
A1 - Avdic,Edina,Pharm.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2017/06/03/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540041/all/Aztreonam
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
